Victory Capital Management
OLMA icon

Victory Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Victory Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Sell
82,030
-121,929
-60% -$1.63M ﹤0.01% 1891
2026
Q1 		$3.04M Buy
203,959
+117,859
+137% +$2.62M ﹤0.01% 1487
2025
Q4 		$2.15M Sell
86,100
-2,050
-2% -$36.5K ﹤0.01% 1565
2025
Q3 		$863K Sell
88,150
-300
-0.3% -$1.8K ﹤0.01% 1917
2025
Q2 		$377K Sell
88,450
-3,860
-4% -$17.2K ﹤0.01% 2107
2025
Q1 		$347K Sell
92,310
-790
-0.8% -$3.97K ﹤0.01% 2111
2024
Q4 		$543K Sell
93,100
-758,412
-89% -$7.57M ﹤0.01% 2009
2024
Q3 		$10.2M Buy
851,512
+76,720
+10% +$981K 0.01% 1105
2024
Q2 		$8.38M Buy
774,792
+164,143
+27% +$1.78M 0.01% 1125
2024
Q1 		$6.91M Sell
610,649
-10,878
-2% -$140K 0.01% 1158
2023
Q4 		$8.72M Buy
621,527
+558,077
+880% +$7.5M 0.01% 1102
2023
Q3 		$784K Buy
+63,450
New +$647K ﹤0.01% 1781

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Victory Capital Management's OLMA Position: Q2 2026 in Review

Victory Capital Management reduced its Olema Pharmaceuticals (OLMA) stake by 60% in Q2 2026, selling an estimated $1.63M and leaving 82,030 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1891.

Victory Capital Management first reported a position in OLMA in Q3 2023 and has held it in 12 quarters since. The position peaked at $10.2M in Q3 2024. 184 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Victory Capital Management held 82,030 shares of Olema Pharmaceuticals worth $1.03M as of Q2 2026.
  • Victory Capital Management sold 121,929 Olema Pharmaceuticals shares in Q2 2026, an estimated $1.63M.
  • Olema Pharmaceuticals made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1891 holding.
  • Victory Capital Management first reported a position in Olema Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • Victory Capital Management's Olema Pharmaceuticals position peaked at $10.2M in Q3 2024.
  • 184 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.